K051107 · Nonin Medical, Inc. · DQA · Jun 1, 2005 · Cardiovascular
Device Facts
Record ID
K051107
Device Name
ONYX II FINGER PULSE OXIMETER, MODEL 9550
Applicant
Nonin Medical, Inc.
Product Code
DQA · Cardiovascular
Decision Date
Jun 1, 2005
Decision
SESE
Submission Type
Special
Regulation
21 CFR 870.2700
Device Class
Class 2
Attributes
Pediatric
Intended Use
The Nonin® Onyx® II Model 9550 Finger Pulse Oximeter is a small, lightweight, portable device indicated for use in measuring and displaying functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. It is intended for spot-checking of adult and pediatric patients on fingers (other than the thumb) between 0.3 - 1.0 inch (0.8 - 2.5 cm) thick. The index finger is the recommended site.
Device Story
Portable finger pulse oximeter; measures SpO2 and pulse rate via red/IR light absorption in perfused tissue. Device contains LEDs and photodetector in finger clip sensor; microprocessor performs signal processing. Output displayed on integrated LED digital display; tricolor LED indicates pulse quality (green/yellow/red). Activated by finger insertion; powers on automatically. Used for spot-checking in clinical or home settings by clinicians or patients. Provides real-time physiological data to assist in assessing patient oxygenation status.
Clinical Evidence
Human oxygenation evaluations conducted to confirm conformance to accuracy and precision specifications. Bench testing performed to verify functional performance. No specific sensitivity/specificity metrics provided in summary.
Technological Characteristics
Finger-clip pulse oximeter; red and infrared LED light source; photodetector sensing; microprocessor-based signal processing; integrated LED digital display; battery-powered; portable form factor.
Indications for Use
Indicated for spot-checking SpO2 and pulse rate in adult and pediatric patients with finger thickness 0.3-1.0 inches (0.8-2.5 cm). Recommended site is index finger.
Regulatory Classification
Identification
An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.
{0}------------------------------------------------
JUN 1 - 2005
K 051107
## Attachment 7
## 510(k) Summary
| Submitter: | Nonin Medical, Inc. |
|-------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Lori M. Roth<br>Clinical/Regulatory Specialist<br>Nonin Medical, Inc.<br>13700 1st Ave. N.<br>Plymouth, MN 55441-5443 |
| Date Prepared: | April 28, 2005 |
| Trade Name: | Model 9550 Onyx® II Finger Pulse Oximeter |
| Classification Name:<br>and Number: | Class II, 21 CFR 870.2700 |
| Product Code: | 74 DQA |
| Predicate Device(s): | The predicate device is the Model 9500 Onyx® Finger<br>Pulse Oximeter, K001085, cleared on May 1, 2000. |
| Device Description: | The Model 9550 Onyx® II is a small, lightweight,<br>portable, finger pulse oximeter that displays numerical<br>values for functional oxygen saturation of arterial<br>hemoglobin (SpO2) and pulse rate by measuring the<br>absorption of red and infrared (IR) light passing<br>through perfused tissue. Changes in the absorption<br>caused by the pulsation of blood in the vascular bed<br>are used to determine oxygen saturation and pulse<br>rate.<br>Light omitting diodes (LEDs) are contained within the<br>sensor along with the photo detector, which is on the<br>opposite side of the probe from the LEDs. The SpO2<br>and heart rate are displayed on the LED digital<br>displays contained within the finger clip sensor. A<br>tricolor LED display provides a visual indication of the<br>pulse quality signal, while blinking at the<br>corresponding pulse rate. This display changes<br>colors to alert you to changes in pulse quality that |
{1}------------------------------------------------
| may affect the readings: green indicates a good pulse<br>quality signal, yellow indicates a marginal pulse<br>quality, and red indicates as inadequate pulse signal.<br>All associated electronics and the microprocessor are<br>within the sensor, which is activated by inserting a<br>patient's finger. This allows the power to be applied<br>to all the internal circuitry upon activation. The device<br>is intended for spot-checking adult and pediatric<br>patients who are well or poorly perfused. | |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use: | The Nonin® Onyx® II Model 9550 Finger Pulse<br>Oximeter is a small, lightweight, portable device<br>indicated for use in measuring and displaying<br>functional oxygen saturation of arterial hemoglobin<br>(SpO2) and pulse rate. It is intended for spot-<br>checking of adult and pediatric patients on fingers<br>(other than the thumb) between 0.3 - 1.0 inch (0.8 -<br>2.5 cm) thick. The index finger is the recommended<br>site. |
| Functional and<br>Safety Testing: | Nonin's Onyx® II Model 9550 Finger Pulse Oximeter<br>has successfully undergone both bench and human<br>testing to support the determination of substantial<br>equivalence. Human oxygenation evaluations were<br>conducted to confirm conformance to accuracy and<br>precision specifications. |
| Conclusion: | Nonin's Onyx® II Model 9550 Finger Pulse Oximeter<br>is substantially equivalent to the predicate devices in<br>terms of accuracy, functional design and principles of<br>operation. Performance test results do not raise new<br>questions of safety and effectiveness when compare<br>to the legally marketed devices. |
:
.
:
:
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three stripes representing the three branches of government. The eagle is surrounded by the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" in a circular arrangement. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 1 - 2005
Ms. Lori M. Roth Clinical/Regulatory Specialist Nonin Medical, Incorporated 13700 15 Avenue North Plymouth, Minnesota 55441-5443
Re: K051107
Trade/Device Name: Onyx® II Model 9550 Regulation Number: 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA Dated: April 28, 2005 Received: May 2, 2005
Dear Ms. Roth:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 -- Ms. Roth
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Chiu Lin, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
## Attachment 2
## Indications for Use Statement
| 510(k) Number (if known) | K051107 |
|--------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device Name | Nonin Medical, Inc. Onyx® II Model 9550 |
| Indications for Use | The Nonin® Onyx® II Model 9550 Finger Pulse Oximeter is a small, lightweight, portable device indicated for use in measuring and displaying functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. It is intended for spot-checking of adult and pediatric patients on fingers (other than the thumb) between 0.3 - 1.0 inch (0.8 - 2.5 cm) thick. The index finger is the recommended site. |
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use × (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 807 Subpart C)
Q.R.
("Ivision Sign-Off) Division of Anesthesiology, General Hospital. Intection Control, Dental Devices
310(k) Number: K051107
Model 9550 Special 510 (K): Device Modification
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.